Q3 2021

Filed Nov 10, 2021 · 10-Q · 41 days after period end · 0001493152-21-027793

Q3 2021 · 10-Q

Revenue

$19.27K

+44.1% vs Q3 2020

Net Income

$15.43M

+2,525.8% vs Q3 2020

EPS Diluted

$0.00

— vs Q3 2020

Gross Profit$9,622−6.3%

Operating Income

Same quarter

Metric	Q3 2021	Q3 2020	Q3 2019	Q3 2018
Revenue	$19.27K	$13.37K	$41.96K	$43.97K
Net Income	$15.43M	$587.77K	-$487.07K	-$967.92K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR